Mediclinic International Past Earnings Performance
Past criteria checks 4/6
Mediclinic International has been growing earnings at an average annual rate of 45%, while the Healthcare industry saw earnings growing at 12.6% annually. Revenues have been growing at an average rate of 2.9% per year. Mediclinic International's return on equity is 5.1%, and it has net margins of 5%.
Key information
45.0%
Earnings growth rate
45.0%
EPS growth rate
Healthcare Industry Growth | 12.6% |
Revenue growth rate | 2.9% |
Return on equity | 5.1% |
Net Margin | 5.0% |
Last Earnings Update | 30 Sep 2022 |
Recent past performance updates
Recent updates
Here's Why We Think Mediclinic International (LON:MDC) Might Deserve Your Attention Today
Jul 26Estimating The Intrinsic Value Of Mediclinic International plc (LON:MDC)
Jul 12Here's Why Mediclinic International (LON:MDC) Can Manage Its Debt Responsibly
Jun 28Are Investors Undervaluing Mediclinic International plc (LON:MDC) By 50%?
Apr 08Is Mediclinic International (LON:MDC) Using Too Much Debt?
Mar 09Mediclinic International (LON:MDC) Takes On Some Risk With Its Use Of Debt
Nov 20Is There An Opportunity With Mediclinic International plc's (LON:MDC) 25% Undervaluation?
Sep 08Is Mediclinic International (LON:MDC) Using Too Much Debt?
Jun 21Does This Valuation Of Mediclinic International plc (LON:MDC) Imply Investors Are Overpaying?
May 26If You Had Bought Mediclinic International's (LON:MDC) Shares Five Years Ago You Would Be Down 63%
Mar 17What Kind Of Shareholders Hold The Majority In Mediclinic International plc's (LON:MDC) Shares?
Feb 26Mediclinic International plc (LON:MDC) Could Be Less Than A Year Away From Profitability
Feb 11Have Mediclinic International plc (LON:MDC) Insiders Been Selling Their Stock?
Jan 27Estimating The Fair Value Of Mediclinic International plc (LON:MDC)
Jan 18These 4 Measures Indicate That Mediclinic International (LON:MDC) Is Using Debt Extensively
Jan 01A Look At Mediclinic International's (LON:MDC) Share Price Returns
Dec 17Our View On Mediclinic International's (LON:MDC) CEO Pay
Dec 02Revenue & Expenses Breakdown
How Mediclinic International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 22 | 3,383 | 169 | 231 | 0 |
30 Jun 22 | 3,308 | 160 | 222 | 0 |
31 Mar 22 | 3,233 | 151 | 213 | 0 |
31 Dec 21 | 3,199 | 135 | 212 | 0 |
30 Sep 21 | 3,165 | 118 | 211 | 0 |
30 Jun 21 | 3,080 | 93 | 208 | 0 |
31 Mar 21 | 2,995 | 68 | 205 | 0 |
31 Dec 20 | 2,987 | -173 | 198 | 0 |
30 Sep 20 | 2,979 | -414 | 190 | 0 |
30 Jun 20 | 3,031 | -367 | 190 | 0 |
31 Mar 20 | 3,083 | -320 | 190 | 0 |
31 Dec 19 | 3,070 | -97 | 329 | 0 |
30 Sep 19 | 3,057 | 126 | 468 | 0 |
30 Jun 19 | 2,995 | -12 | 593 | 0 |
31 Mar 19 | 2,932 | -151 | 717 | 0 |
31 Dec 18 | 2,897 | -380 | 728 | 0 |
30 Sep 18 | 2,861 | -610 | 739 | 0 |
30 Jun 18 | 2,869 | -551 | 741 | 0 |
31 Mar 18 | 2,876 | -492 | 743 | 0 |
31 Dec 17 | 2,874 | -211 | 742 | 0 |
30 Sep 17 | 2,871 | 69 | 741 | 0 |
30 Jun 17 | 2,810 | 149 | 715 | 0 |
31 Mar 17 | 2,749 | 229 | 689 | 0 |
31 Dec 16 | 2,565 | 210 | 667 | 0 |
30 Sep 16 | 2,380 | 191 | 644 | 0 |
30 Jun 16 | 2,244 | 184 | 599 | 0 |
31 Mar 16 | 2,107 | 177 | 554 | 0 |
31 Dec 15 | 2,080 | 211 | 527 | 0 |
30 Sep 15 | 2,183 | 257 | 530 | 0 |
30 Jun 15 | 2,042 | 245 | 492 | 0 |
31 Mar 15 | 1,977 | 241 | 471 | 0 |
31 Dec 14 | 1,901 | 221 | 433 | 0 |
30 Sep 14 | 1,810 | 199 | 399 | 0 |
30 Jun 14 | 1,751 | 193 | 382 | 0 |
31 Mar 14 | 1,738 | 193 | 374 | 0 |
31 Dec 13 | 1,652 | 82 | 360 | 0 |
30 Sep 13 | 1,653 | -33 | 366 | 0 |
30 Jun 13 | 1,701 | -55 | 377 | 0 |
31 Mar 13 | 1,742 | -79 | 387 | 0 |
31 Dec 12 | 1,729 | 19 | 386 | 0 |
30 Sep 12 | 1,730 | 118 | 388 | 0 |
30 Jun 12 | 1,759 | 109 | 397 | 0 |
Quality Earnings: MDC has high quality earnings.
Growing Profit Margin: MDC's current net profit margins (5%) are higher than last year (3.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MDC's earnings have grown significantly by 45% per year over the past 5 years.
Accelerating Growth: MDC's earnings growth over the past year (43.2%) is below its 5-year average (45% per year).
Earnings vs Industry: MDC earnings growth over the past year (43.2%) exceeded the Healthcare industry 3.8%.
Return on Equity
High ROE: MDC's Return on Equity (5.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2023/05/31 21:02 |
End of Day Share Price | 2023/05/26 00:00 |
Earnings | 2022/09/30 |
Annual Earnings | 2022/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Mediclinic International plc is covered by 18 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Sean Ungerer | Arqaam Capital Research Offshore S.A.L. |
Simon Mather | Barclays |
Victoria Lambert | Berenberg |